GTC is proud to present the 6th Oncology Biomarkers Conference as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the oncology biomarker field such as novel approaches to biomarker discovery, diagnostic and therapeutic development for cancer, utilization of next-generation sequencing in the clinic, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:

March 20th

Plenary Keynote Session

March 21st-22nd

Breakout: Oncology Biomarkers

 Diagnostics & Therapeutic Development for Cancer

Overcoming Challenges of Clinical Translation

Circulating/Body-Fluid Biomarkers in Oncology

Proteomic Platforms

- Mass spectrometry / Maldi

- Array

Bioinformatics in Oncology Biomarkers

- Next-Generation Sequencing

- Multiplexing Platforms

- Digital Pathology Solutions